We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
ForewordFree Access

Welcome to the 15th volume of Future Microbiology

    Atiya Henry

    *Author for correspondence:

    E-mail Address: a.henry@futuremedicine.com

    Future Science Group, Unitec House, 2 Albert Place, London, N31QB, UK

    Search for more papers by this author

    Published Online:11 Feb 2020https://doi.org/10.2217/fmb-2020-0020
    Free first page

    References

    • 1. Moore AY, Charles JE, Moore S. Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris. Future Microbiol. 14(14), 1235–1242 (2019).
      CASGoogle Scholar
    • 2. Pennington H. The impact of infectious disease in war time: a look back at WW1. Future Microbiol. 14(3), 165–168 (2019).
      CASGoogle Scholar
    • 3. Wilcox M, Al-Obeid S, Gales A et al. Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group. Future Microbiol. 14(4), 345–352 (2019).
      CASGoogle Scholar
    • 4. Arastehfar A, Fang W, Daneshnia F et al. Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples. Future Microbiol. 14(1), 33–45 (2019).
      Google Scholar
    • 5. Van Damme P, Coster ID, Bandyopadhyay AS et al. Poliopolis: pushing boundaries of scientific innovations for disease eradication. Future Microbiol. 14(15), 1321–1330 (2019).
      CASGoogle Scholar
    • 6. Vickers RJ, Bassetti M, Clancy CJ et al. Combating resistance while maintaining innovation: the future of antimicrobial stewardship. Future Microbiol. 14(15), 1331–1341 (2019).
      CASGoogle Scholar
    • 7. Saxena SK, Kumar S, Maurya VK. Pathogen-associated acute encephalitis syndrome: therapeutics and management. Future Microbiol. 14(4), 259–262 (2019).
      CASGoogle Scholar
    • 8. Linkedin group: Future Science Group Microbiology. www.linkedin.com/groups/8506116.
      Google Scholar
    • 9. Infectious Diseases Hub. www.id-hub.com.
      Google Scholar
    • 10. Future Science Group. www.future-science-group.com/.
      Google Scholar
    • 11. A peek behind the paper – Sidharth Chopra on drug repurposing to tackle antimicrobial resistance. ID Hub (2019). www.id-hub.com/2019/09/05/peek-behind-paper-sidharth-chopra-drug-repurposing-tackle-antimicrobial-resistance/.
      Google Scholar
    • 12. Kaul G, Shukla M, Dasgupta A, Chopra S. Update on drug-repurposing: is it useful for tackling antimicrobial resistance? Future Microbiol. 14(10), 829–831 (2019).
      CASGoogle Scholar
    • 13. Future Microbiol. Twitter. https://twitter.com/fsgfmb.
      Google Scholar